17:08 , Apr 6, 2018 |  BC Week In Review  |  Financial News

CMAB raises $34M for manufacturing upgrade

CMAB Biopharma Inc. (Suzhou, China) raised $34 million on April 2 in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed. CMAB, a...
16:21 , Apr 2, 2018 |  BC Extra  |  Financial News

CMAB raises $34M for manufacturing upgrade

CMAB Biopharma Inc. (Suzhou, China) raised $34 million in a series B round led by new investor CD Capital. Also participating were C-Bridge Capital, Cormorant, Qianhai FoF Fund and Tigermed. CMAB said it will upgrade...
21:18 , Jan 5, 2018 |  BC Week In Review  |  Financial News

CMAB raises $38M series A

CMAB Biopharma Inc. (Suzhou, China) raised $38 million on Jan. 2 in a series A round led by C-Bridge Capital and BioBay. I-Bridge Capital and Qianhai FoF fund also participated. The contract development and manufacturing...
16:47 , Jan 2, 2018 |  BC Extra  |  Financial News

CMAB raises $38M series A

CMAB Biopharma Inc. (Suzhou, China) raised $38 million in a series A round led by C-Bridge Capital and BioBay. I-Bridge Capital and Qianhai FoF fund also participated. The contract development and manufacturing organization follows global...
08:00 , Nov 13, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

Kai-Jye Lou and Stephen Parmley, Senior Writers, and Mark Zipkin, Staff Writer  Tankyrase translation   With a few pharmas entering the search for tankyrase inhibitors for cancer, Merck KGaA is hedging its bets by joining...
08:00 , Nov 3, 2014 |  BC Week In Review  |  Company News

J&J pharmaceuticals news

Johnson & Johnson launched its Asia-Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the areas of...
08:00 , Nov 3, 2014 |  BioCentury  |  Strategy

Translation in Asia

The low concentration of entrepreneurs and venture money in the Asia-Pacific region means Johnson & Johnson 's newest innovation center will initially go about making early stage deals and investments differently than its counterparts in...
04:41 , Oct 29, 2014 |  BC Extra  |  Company News

New deals for J&J's Asia-Pacific Innovation Center

Johnson & Johnson (NYSE:JNJ) launched its Asia Pacific Innovation Center, the fourth of J&J's centers. Located in Shanghai with satellite offices in Singapore, Australia and Japan, the center will identify early stage innovations in the...
07:00 , Sep 18, 2014 |  BC Innovations  |  Translation in Brief

Translational tidbits

Chris Cain, Associate Editor, and Kai-Jye Lou, Senior Writer RNA sequencing standardized The FDA has convened a consortium to review the status of RNA sequencing for drug development and outline hurdles for incorporating the technology...
07:00 , Sep 8, 2014 |  BC Week In Review  |  Company News

Huya, Changzhou Center for Biotech Development deal

Huya will have the first opportunity to evaluate R&D projects supported by the Changzhou Center for Biotech Development (CZCBD) in exchange for providing expertise in drug development and commercialization. Huya focuses on establishing collaborations to...